Work

Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery

Year: 2022

Type: article

Source: Obesity Surgery

DOI: 10.1007/s11695-022-06044-6

Authors: Mitesh Sharma, Rahul Nayar, Yitka Graham, Helen M. Parretti, Sally Abbott, Abd Tahrani, Alexander D. Miras, Brijesh Madhok, Rishi Singhal, Kamal Mahawar

Institutions: Sunderland Royal Hospital, South Tyneside and Sunderland NHS Foundation Trust, University of Sunderland, University of East Anglia, University Hospital Coventry, University Hospitals Coventry and Warwickshire NHS Trust, Novo Nordisk (Denmark), University of Birmingham, Imperial College London, University Hospitals of Derby and Burton NHS Foundation Trust, Heartlands Hospital

Language: English

Topic: Bariatric Surgery and Outcomes

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4225100117

FWCI: 0.852

Cites: 7

Cited by: 5

Related to: 10